source
- ARPA-H commits $62.7 million to develop FDA-authorized AI for heart-failure treatmentARPA-H announced a $62.7 million investment to create artificial-intelligence systems that can assist in treating heart failure. The program, called ADVOCATE, seeks to develop partially autonomous…
- Scientists who discovered orexin receive Lasker Award as FDA appoints permanent heads of key drug and biologics centersThe team that identified the orexin system has been honored with a Lasker Award, one of the nation’s most prestigious biomedical recognitions. The award highlights the impact of their work on under…